Curadev Pharma
-
Curadev Pharma announces clinical advisory group
Curadev recently received permission from the US FDA to commence FIH trials with systemically administered CRD3874 in patients with advanced/metastatic…
Read More » -
Curadev Pharma bags ‘Study May Proceed’ letter from US FDA
The study will be performed at a leading US cancer centre Curadev Pharma, a small molecule drug discovery and development…
Read More »